The epidemiology of endometriosis

Missmer SA, Stacey A. Missmer, Cramer DW, Daniel W. Cramer
Obstetrics and Gynecology Clinics of North America · 2003 · vol. 30(1) , pp. 1–19 · doi:10.1016/s0889-8545(02)00050-5 · PMID:12699255 · W2015634215
Review OA: closed CC0 ⤵ 304 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-09 ⓘ

This paper examines the occurrence, distribution, and determinants of endometriosis within populations.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The epidemiologic study of endometriosis presents researchers with unique challenges. As a result, few well-designed studies have been published. The authors briefly describe the primary pathogenic hypotheses, discuss methodologic issues specific to endometriosis, and review the small body of literature addressing risk factors. Finally, they offer a brief interpretation of these findings and suggest hypotheses for future research.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Adolescent Adolescent Adult Adult Endometriosis Endometriosis Endometriosis Epidemiologic Research Design Epidemiologic Research Design Female Female Humans Humans Middle Aged Middle Aged Risk Factors Risk Factors

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (97)

Cited by (50)

Source provenance

europepmc
last seen: 2026-10-13T06:10:10.580696+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:00:58.458861+00:00
unpaywall
last seen: 2026-10-13T06:25:51.201866+00:00
License: CC0 · commercial use OK